Pfizer’s Wall Street critic-turned-executive digs into the company’s problems, obesity plans Andrew Baum is tasked with selling the company’s R&D plans to investors

https://www.statnews.com/2025/03/20/pfizer-andrew-baum-innovation-strategy-revenues-danuglipron/